Key Developments For Medtox Scientific, Inc.

Medtox Scientific, Inc. (MTOX.O) (Nasdaq)
As of  27 Nov 2009
9.00USD
Price Change
+0.40
Percent Change
+4.59%
 
Research Another Stock: Symbol Look-up

Medtox Scientific, Inc. Receives FDA 510(k) Clearance for Additional Three Drugs On The PROFILE-V MEDTOXScan Drugs-of-Abuse Test System
Wednesday, 29 Jul 2009 09:02am EDT 

Medtox Scientific, Inc. announced that on July 24, 2009, it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its PROFILE-V MEDTOXScan Drugs-of-Abuse Test System with three additional drugs -- Oxycodone, Propoxyphene and Tricyclic Anitidepressants. 

 
Medtox Scientific, Inc. Receives FDA 510(K) Clearance for PROFILE-V MEDTOXScan Drugs-of-Abuse Test System
Thursday, 19 Feb 2009 02:24pm EST 

Medtox Scientific, Inc. announced that on February 13, 2009, it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its PROFILE-V MEDTOXScan Drugs-of-Abuse Test System. 

 
Medtox Scientific, Inc. Files Application With FDA For MEDTOXScan-DJ
Tuesday, 11 Mar 2008 02:33pm EDT 

Dow Jones reported that Medtox Scientific, Inc., filed a 510(k) application with the Food and Drug Administration for prescription use of its MEDTOXScan reader that is used with its drugs-of-abuse diagnostic devices. MEDTOXScan is an electronic scanner that tests for drug and chemical abuse. 

 
Medtox Scientific, Inc. Shares Fall Sharply on Q2 Results Announcement-Reuters
Tuesday, 17 Jul 2007 02:52pm EDT 

Reuters reported that shares of Medtox Scientific, Inc. dropped sharply, after the Company reported higher quarterly profit but fell short of analysts' expectations. The company posted second-quarter earnings of $1.8 million, or 20 cents a share. 

 
Medtox Scientific, Inc. Announces Contract With Los Angeles County Probation Department
Wednesday, 12 Jul 2006 12:40pm EDT 

MEDTOX Scientific, Inc. announced that the Los Angeles County Board of Supervisors approved a contract between MEDTOX Scientific and the Los Angeles County Probation Department at their meeting on July 11, 2006. MEDTOX will provide to the Probation Department its ClearCourse Solution, which includes the Company's DARS (Drug Abuse Recognition System) training. The contract term is one year with four one year extensions. Based on the Los Angeles County Board's approval, the value of the contract is estimated at $1.15 million per year. Additionally, Oklahoma Community Corrections, the Kansas Department of Corrections and several of the Texas Community Services & Corrections Division locations have started using a combination of the ClearCourse Solution and/or the Company's point-of-collection screening devices. 

 
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.